Skip to main content
SpringerLink
Log in

Individualized drug utilization statistics

Analysing a population's drug use from the perspective of individual users

  • Pharmacokinetics And Disposition
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

The Danish retail pharmacies' drug subsidy system is completely computerized. The data are person-identifiable, making it possible to chart the population's drug use from the perspective of individual users. We decided to explore the potential of this data source and to analyse heavy drug users specifically.

The analysis encompassed all 890 352 prescriptions presented by citizens of Odense in 1991. There was a total sales volume of 32 million defined daily doses consumed by 113 468 adult drug users, corresponding to 65.1% of the adult population. We found 2388 heavy drug users, defined by an annual purchase of more than 2000 defined daily doses. Heavy drug users accounted for 1.4% of the adult population and 22.9% of drug sales. They were remarkably well characterized by their main therapeutic class, which constituted a median of 47% of their drug use. A median of 97% of each heavy user's drugs were issued by one main prescriber. We conclude that heavy drug use can generally be ascribed to severe disease rather than to irresponsible prescribing.

For the most important drug classes, we present various epidemiological measures of drug use, including 1-year prevalence, incidence, duration of therapy and some measures of skewness in utilization. If analysed regularly these measures can disclose subtle trends in clinical drug use that would not be evident from the wholesale figures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anonymous (1993) Nordic statistics on medicines 1990–92. Nordic Council of Medicines, Uppsala

  2. Montanaro N, Vaccheri A, Magrini N, Battilana M (1992) Farmaguida: a databank for the analysis of the Italian drug market and drug utilization in general practice. Eur J Clin Pharmacol 42: 395–399

    Google Scholar 

  3. Hallas J, Hansen NCG (1993) Individual utilization of antiasthma medication by young adults: a prescription database analysis. J Intern Med 234: 65–70

    Google Scholar 

  4. Anonymous (1991) Drug utilization in Denmark 1990 (in Danish). Dansk Laegemiddelstatistik, Copenhagen

  5. Anonymous (1991) The Danish population 1 January 1991 (in Danish). Danmarks Statistik, Copenhagen

  6. Dukes MNG (1993) Introduction. In: Dukes MNG (ed) Drug utilization studies: methods and uses. European Series No. 45, WHO Regional Publications, Geneva, pp. 1–4

    Google Scholar 

  7. Rothman KJ (1986) Modern epidemiology. Little, Brown and Co., Boston, p. 33

    Google Scholar 

  8. Isakson D (1987) Heavy drug users. Pharmacoepidemiological studies in a Swedish community. Thesis, University of Uppsala

  9. Armstrong EP, Terry AK (1992) Impact of drug use evaluation upon ambulatory pharmacy practice. Ann Pharmacother 26: 1546–1553

    Google Scholar 

  10. Capella D, Porta M, Laporte JR (1983) Utilization of antihypertensive drugs in certain European countries. Eur J Clin Pharmacol 25: 431–435

    Google Scholar 

  11. National Heart, Lung and Blood Institute (1992) International consensus report on diagnosis and treatment of asthma. Eur Respir J 5: 601–641

    Google Scholar 

  12. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE (1990) Effect of long-term treatment with an inhaled corticosteroid on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 142: 832–836

    Google Scholar 

  13. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K et al. (1991) Comparison of a β2-agonist, terbutaline, with an inhaled corticosteroid, budenoside, in newly detected asthma. N Engl J Med 325: 388–392

    Google Scholar 

  14. Callahan CM, Dittus RS, Katz BP (1991) Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med 114: 216–223

    Google Scholar 

  15. Anonymous (1993) Drug utilization in Denmark 1987–92 (in Danish). Sundhedsstyrelsen, Brønshøj

  16. Hörnsten P, Keisu M, Wiholm BE (1990) The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden 1972–1988. Arch Dermatol 26: 919–922

    Google Scholar 

  17. Jick SS, Jick H, Walker AM, Hunter JR (1989) Hospitalization for pulmonary reactions following nitrofurantoin use. Chest 96: 512–515

    Google Scholar 

  18. Green A, Hauge M, Holm NV, Rasch LL (1981) Epidemiological studies of diabetes mellitus in Denmark. Diabetologia 20: 468–470

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, Odense Universitet, Winsløwsparken 19 III, DK-5000, Odense C, Denmark

    J. Hallas

  2. National Board of Health, Division of Medicines, Copenhagen, Denmark

    A. Nissen

Authors
  1. J. Hallas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Nissen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hallas, J., Nissen, A. Individualized drug utilization statistics. Eur J Clin Pharmacol 47, 367–372 (1994). https://doi.org/10.1007/BF00191170

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00191170

Key words

Search

Navigation